ArticleJournal of research in pharmacy practice

Reduced Weekly Subcutaneous Doses of Bortezomib in Combination with Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma.

Farzaneh Ashrafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.